DEL-30

N/A

Report date: 2023/03/12 14:49:29

Base Information

Drug NameDEL-30
Drug Alias NameDEL-30
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFibroblast growth factor 19 modulatorsGene transference
TargetsFibroblast growth factor 19
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNGM Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNGM Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A